| 标题： | 中成药短缺药评价专家共识 |
| title： | Expert consensus on the evaluation of shortage of Chinese patent medicine |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 相关医疗机构。 |
| Guide users： | Relevant medical institutions. |
| 证据分级方法： | 本研究以专家共识意见为主，不设定证据分级方法 |
| Evidence grading method： | This study is based on expert consensus and does not set evidence grading method |
| 制定单位： | 首都医科大学宣武医院；北京市药品使用监测和临床综合评价中心 |
| Formulating unit： | Xuanwu Hospital of Capital Medical University; Beijing Center for Drug Use Monitoring and Clinical Comprehensive Evaluation |
| 注册时间： | 2024-04-10 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN517 |
| Registration number： | |
| 指南制订的目的： | 为指导医疗机构客观、公正开展中成药短缺品种评价工作，促进医疗机构内药品的供应保障和优胜劣汰，保障患者接受安全、有效、经济、稳定的药物治疗，特制定本专家共识。 |
| Purpose of the guideline： | In order to guide medical institutions to objectively and fairly evaluate the shortage of Chinese patent medicines, promote the supply guarantee of drugs in medical institutions, and guarantee patients receive safe, effective, economic and stable drug treatment, this expert consensus was formulated. |
